Health Condition 1: E112- Type 2 diabetes mellitus with kidney complications Health Condition 2: E119- Type 2 diabetes mellitus without complications
Conditions
Interventions
Intervention1: NIL: NIL
Control Intervention1: NIL: NIL
Sponsors
Dr Vignesh Kumar
Eligibility
Inclusion criteria
Inclusion criteria: 1. Persons with type 2 diabetes without nephropathy or other complications 2. Persons with type 2 diabetes with CKD
Exclusion criteria
Exclusion criteria: 1. Patients having low glomerular filtration rate (GFR) without microalbuminuria will be excluded from the study. 2. Patients with type 1 DM 3. Febrile patients/patients with infections including urinary tract infection (UTI), respiratory tract infections, gastrointestinal infection, otitis media, viral hepatitis, parasitic infection, viral infection, tuberculosis, local infection, skin infection, AIDS, pyrexia of unknown origin, and any other infectious disease. 4. Patients with systemic disorder such as cardiovascular disease, chronic liver disease, blood disorders, autoimmune disorders, malignancy, poisoning; 5. Patients on anti-inflammatory drugs, systemic or topical steroids, alcohol; 6. Patients with uncontrolled blood pressure (BP); 7. Patients having diseases affecting urinary protein excretion as nephritic syndrome, urolithiasis, renal insufficiency, renal artery stenosis, dehydration state, and UTI
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The association of Neutrophil Lymphocyte Ratio and Renal function will be studied. Predictive value of Neutrophil Lymphocyte ratio for Chronic Kidney disease in diabetics will be assessed and compared to that of Platelet Lymphocyte ratio, High Sensitive C Reactive Protein, and Urine MicroalbuminuriaTimepoint: 18 months | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Public ContactVignesh Kumar
Dr. TMA Pai Hospital
Outcome results
None listed